Chengcheng Zhang

12PUBLICATIONS
77CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 03, 2026
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer.

Xiaoye Liu, Ryan Huang, Zhiqiang Ku

|Mar 13, 2026
IL-7/IL-15/IL-21 cytokine-fusion scaffold generates highly functional CAR T cells enriched in long-lived T memory stem cells.

Erin B Cole, Sara Lamcaj, Agnes V Sydenstricker

|Nov 13, 2025
Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptors.

Chengcheng Zhang, Yubo He, Xiaoye Liu

|Jul 24, 2025
Secretogranin 2 binds LILRB4 resulting in immunosuppression.

Xing Yang, Ryan Huang, Meng Fang

|Mar 27, 2025
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development.

Yubo He, Chengcheng Zhang, Lingxiao Tan

|Dec 12, 2024
A Switch Protein Adapter for Anti-LILRB4 CAR-T Cells.

Ryan Huang, Heyu Chen, Jingjing Xie

Pageof 2

Frequent Collaborators

6 joint publications

Zhiqiang An

5 joint publications

Ningyan Zhang

3 joint publications

Cheryl Lewis

3 joint publications

Meng Fang